Filter
4670
Text search:
drug
policy
Featured
Recommendations
388
New Publications
1251
Language
Document type
No document type
2818
Studies & Reports
734
Guidelines
555
Manuals
201
Strategic & Response Plan
170
Fact sheets
59
Training Material
53
Situation Updates
47
Infographics
11
Resource Platforms
9
Brochures
5
Online Courses
5
App
2
Countries / Regions
India
219
Global
160
Kenya
156
Uganda
118
South Africa
117
Western and Central Europe
108
Nigeria
105
Ethiopia
104
Nepal
92
Liberia
80
Sierra Leone
79
Tanzania
79
Malawi
79
Zambia
77
Myanmar / Burma
73
Ghana
71
Africa
69
Latin America and the Carribbean
67
Bangladesh
63
Eastern Europe
59
Namibia
56
Ukraine
54
Rwanda
53
Asia
43
Zimbabwe
42
Philippines
36
South–East Asia Region
36
Cambodia
35
Lesotho
35
Russia
33
Indonesia
32
Botswana
28
Mozambique
22
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Senegal
19
Syria
19
Burkina Faso
18
East and Southern Africa
16
Brazil
15
West and Central Africa
13
Haiti
12
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Pakistan
11
South Sudan
11
Thailand
11
Eastern Europe and Central Asia
11
Guinea
10
Albania
10
Tajikistan
10
Georgia
10
Germany
9
Sudan
9
Vietnam
9
China
8
Afghanistan
7
Laos
7
Moldova
7
USA
6
Benin
6
North Macedonia
6
Sri Lanka
6
Yemen
6
Paraguay
6
Armenia
6
Peru
5
El Salvador
5
Mexico
5
Western Pacific Region
5
North America
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
Libya
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Bhutan
3
Palestine
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
Honduras
1
Greece
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1871
Clinical Guidelines
360
Public Health
228
Women & Child Health
169
Key Resources
138
Capacity Building
55
Pharmacy & Technologies
51
Toolboxes
HIV
622
TB
515
Mental Health
418
AMR
248
COVID-19
167
Pharmacy
137
NTDs
122
NCDs
90
Malaria
86
Caregiver
82
Planetary Health
66
Ebola & Marburg
57
Global Health Education
56
Disability
53
Refugee
51
Conflict
46
Rapid Response
45
Health Financing Toolbox
43
Polio
24
2.0 Rapid Response
23
Natural Hazards
15
Specific Hazards
13
Cholera
10
Social Ethics
10
Zika
7
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is
...
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi
...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
Bangladesh Health Systems in Transition